Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Phase 4

Recruiting

• Conditions: Hip Arthroscopy
• Interventions: Drug: Ibuprofen; Drug: Oxycodone; Drug: Gabapentin; Drug: Acetaminophen; Drug: Methocarbamol

• Registration Number: NCT05076110
• Lead Sponsor: Mayo Clinic

Brief Summary

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-09-29
• Study First Submitted QC: 2021-09-29
• Study First Posted: 2021-10-13
• Study Start: 2022-04-07
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-14
• Last Update Posted: 2024-06-18
• Primary Completion: 2025-04
• Study Completion: 2025-04

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 188

Inclusion Criteria

• Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN)

Exclusion Criteria

• medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin.
• Substantial alcohol or drug abuse.
• History of narcotics within 6 months of surgery.
• Pregnancy.
• Renal impairment.
• Peptic ulcer disease.
• GI bleeding.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Non-Opiate Pain Control Group	Ibuprofen	Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.
Standard of Care Group	Oxycodone	Subjects will receive standard of care pain medication Oxycodone for pain control following hip arthroscopy procedure
Non-Opiate Pain Control Group	Acetaminophen	Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.
Non-Opiate Pain Control Group	Gabapentin	Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.
Non-Opiate Pain Control Group	Methocarbamol	Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

Primary Outcome Measures

Name	Time	Method
Change in pain score	Baseline, 14 days post-operatively	Measure using a visual analog scale (VAS) to rate pain on a scale 0-10; 0=no pain to 10=worst possible pain

Trial Locations

Locations (1)

Mayo clinic; 🇺🇸 Rochester, Minnesota, United States